On Monday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.2 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.1. The stock opened at $27.52 ...
Royalty Pharma (RPRX) and Syndax Pharmaceuticals (SNDX) announced that Royalty Pharma has entered into a $350M synthetic royalty funding ...
Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax through profitability; proforma cash approaching $800 ...
Syndax Pharmaceuticals (Nasdaq: SNDX) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Syndax has entered into a $350 million synthetic royalty funding agreement with Royalty Pharma based on ...
Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax through profitability; proforma cash approaching $800 mil ...
Tensions flared in Belagavi, Karnataka, after a poster depicting Mughal emperor Aurangzeb as the "real founder of Akhand Bharat" was removed by police. The poster, installed by unidentified youths ...
Dozens of candidates are running in the 2024 presidential election apart from Kamala Harris and Donald Trump, which may influence the final result in the tight race. None is on a realistic path to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback